Development of verteporfin therapy: A collaboration between pharmaceutical companies, device manufacturers and clinical investigators

Author： Huber Gustave   Levy Julia  

Publisher： Informa Healthcare

ISSN： 0882-0538

Source： Seminars in Ophthalmology, Vol.16, Iss.4, 2001-12, pp. : 213-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Description of Ophthalmic Pharmaceutical and Device Start-Up Companies

By  

Ophthalmic Research, Vol. 54, Iss. 1, 2015-05 ,pp. : 6-9

Karger

Access to resources Recommend Favorite

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: From clinical trials to clinical practice

By Sickenberg Michel  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 207-212

Informa Healthcare

Access to resources Recommend Favorite

Experimental Inhibition of Corneal Neovascularization by Photodynamic Therapy with Verteporfin

By Yoon Kyung-Chul   Ahn Kyu   Lee Song   Kim Kyung   Im Seong-Kyu   Oh Han-Jin   Jeong In-Young   Park Sang-Woo   Park Yeoung-Geol   Nah Hyeon-Ju   Im Wook-Bin  

Current Eye Research, Vol. 31, Iss. 3, 2006-03 ,pp. : 215-224

Informa Healthcare

Access to resources Recommend Favorite

Photodynamic therapy with verteporfin: A new treatment in ophthalmology

By Michels Stephan   Schmidt-Erfurth Ursula  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 201-206

Informa Healthcare

Access to resources Recommend Favorite

Photodynamic Therapy with Verteporfin for Polypoidal Choroidal Vasculopathy of the Macula

By  

Ophthalmologica, Vol. 218, Iss. 3, 2004-04 ,pp. : 193-201

Karger

Access to resources Recommend Favorite